Evercore ISI Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX)
In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...
StockStory.org on MSN16d
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack
The stock is up 8.6% since reporting and currently trades at $510.02. Is now the time to buy Vertex Pharmaceuticals? Access our full analysis of the earnings results here, it’s free. Pioneering ...
pharmaphorum2d
Levicept says non-opioid drug cuts arthritis pain in phase 2
Neurotrophin-3 (NT-3) inhibitor LEVI-04 hit all its primary and secondary objectives in the trial, which enrolled 510 patients with ... in acute pain, with Vertex Pharma filing for approval ...
Yahoo Finance7d
DE Mar 2025 510.000 call (DE250328C00510000)
As of 26 March at 10:01:43 GMT-4. Market open. Vertex Baseline Delta ...
Yahoo Finance9d
SPY Mar 2025 510.000 call (SPY250325C00510000)
As of 24 March at 10:42:58 am GMT-4. Market open. Vertex Baseline Delta ...